SCHEMBL20291983

SCHEMBL20291983

CC(C)(C)OC(=O)N1CCC(N2CCC[C@H]2C(F)(F)F)CC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.49
EPHX1 P07099 1/20 0.47
RECQL P46063 1/20 0.44
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GPR119 Q8TDV5 3/20 0.41
HCAR1 Q9BXC0 1/20 0.41
MAPT P10636 2/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 1/20 0.40
THRB P10828 1/20 0.40
PTPN2 P17706 1/20 0.40
PTPN1 P18031 1/20 0.40
PTPN6 P29350 1/20 0.40
STS P08842 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20292085 1.00 HPGD (0.49) HPGDEPHX1RECQLUSP2SMN1; SMN2
SCHEMBL2475425 0.81 HPGD (0.52) HPGDEPHX1RECQLUSP2SMN1; SMN2
SCHEMBL18702077 0.81 SPR (0.39) ALDH1A1
SCHEMBL2475421 0.81 HPGD (0.52) HPGDEPHX1RECQLUSP2SMN1; SMN2
SCHEMBL18711299 0.81 SPR (0.40) EPHX1SMN1; SMN2MEN1KMT2A
SCHEMBL1720172 0.81 HPGD (0.49) HPGDEPHX1RECQLUSP2SMN1; SMN2
SCHEMBL1085043 0.81 HPGD (0.49) HPGDEPHX1RECQLUSP2SMN1; SMN2
SCHEMBL1085044 0.81 HPGD (0.49) HPGDEPHX1RECQLUSP2SMN1; SMN2
SCHEMBL20292138 0.80 HPGD (0.48) HPGDEPHX1RECQLUSP2SMN1; SMN2
SCHEMBL20292088 0.80 HPGD (0.48) HPGDEPHX1RECQLUSP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4714446-A2 PHARMACEUTICAL COMPOUNDS Nxera Pharma UK Limited (GB) 2026-03-25 EP disclosed
EP-4413985-A2 PHARMACEUTICAL COMPOUNDS Nxera Pharma UK Limited (GB) 2024-08-14 EP disclosed
EP-3406609-A1 BICYCLIC AZA COMPOUNDS AS MUSCARINIC RECEPTOR AGONISTS Heptares Therapeutics Limited (GB) 2018-11-28 EP disclosed
EP-3102568-B1 BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AGONISTS. HEPTARES THERAPEUTICS LTD (GB) 2018-06-27 EP disclosed